Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen.
Saved in:
| Title: | Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen. |
|---|---|
| Authors: | Helland T; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Norway., Naume B; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway., Hustad S; Core Facility for Metabolomics, Department of Clinical Science, University of Bergen, Norway., Bifulco E; Core Facility for Metabolomics, Department of Clinical Science, University of Bergen, Norway., Kvaløy JT; Department of Mathematics and Physics, University of Stavanger, Norway.; Department of Research, Stavanger University Hospital, Norway., Saetersdal AB; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway., Synnestvedt M; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway., Lende TH; Department of Surgery, Section for Breast and Endocrine Surgery, Stavanger University Hospital, Norway., Gilje B; Department of Oncology and Radiotherapy, Stavanger University Hospital, Norway., Mjaaland I; Department of Oncology and Radiotherapy, Stavanger University Hospital, Norway., Weyde K; Department of Oncology, Sykehuset Innlandet, Gjøvik, Norway., Blix ES; Immunology Research Group, Institute of Medical Biology, University of Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Wiedswang G; Department of GI-Surgery, Oslo University Hospital, Norway., Borgen E; Department of Pathology, Oslo University Hospital, Norway., Hertz DL; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, USA., Janssen EAM; Department of Pathology, Stavanger University Hospital, Norway.; Department of Bioscience and Environmental Engineering, University of Stavanger, Norway., Mellgren G; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Norway., Søiland H; Department of Clinical Science, University of Bergen, Norway.; Department of Oncology and Radiotherapy, Stavanger University Hospital, Norway. |
| Source: | Molecular oncology [Mol Oncol] 2021 Apr; Vol. 15 (4), pp. 957-967. Date of Electronic Publication: 2020 Dec 14. |
| Publication Type: | Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33252186 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Helland+T%22">Helland T</searchLink>; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Naume+B%22">Naume B</searchLink>; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Hustad+S%22">Hustad S</searchLink>; Core Facility for Metabolomics, Department of Clinical Science, University of Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Bifulco+E%22">Bifulco E</searchLink>; Core Facility for Metabolomics, Department of Clinical Science, University of Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Kvaløy+JT%22">Kvaløy JT</searchLink>; Department of Mathematics and Physics, University of Stavanger, Norway.; Department of Research, Stavanger University Hospital, Norway.<br /><searchLink fieldCode="AU" term="%22Saetersdal+AB%22">Saetersdal AB</searchLink>; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway.<br /><searchLink fieldCode="AU" term="%22Synnestvedt+M%22">Synnestvedt M</searchLink>; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway.<br /><searchLink fieldCode="AU" term="%22Lende+TH%22">Lende TH</searchLink>; Department of Surgery, Section for Breast and Endocrine Surgery, Stavanger University Hospital, Norway.<br /><searchLink fieldCode="AU" term="%22Gilje+B%22">Gilje B</searchLink>; Department of Oncology and Radiotherapy, Stavanger University Hospital, Norway.<br /><searchLink fieldCode="AU" term="%22Mjaaland+I%22">Mjaaland I</searchLink>; Department of Oncology and Radiotherapy, Stavanger University Hospital, Norway.<br /><searchLink fieldCode="AU" term="%22Weyde+K%22">Weyde K</searchLink>; Department of Oncology, Sykehuset Innlandet, Gjøvik, Norway.<br /><searchLink fieldCode="AU" term="%22Blix+ES%22">Blix ES</searchLink>; Immunology Research Group, Institute of Medical Biology, University of Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Wiedswang+G%22">Wiedswang G</searchLink>; Department of GI-Surgery, Oslo University Hospital, Norway.<br /><searchLink fieldCode="AU" term="%22Borgen+E%22">Borgen E</searchLink>; Department of Pathology, Oslo University Hospital, Norway.<br /><searchLink fieldCode="AU" term="%22Hertz+DL%22">Hertz DL</searchLink>; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Janssen+EAM%22">Janssen EAM</searchLink>; Department of Pathology, Stavanger University Hospital, Norway.; Department of Bioscience and Environmental Engineering, University of Stavanger, Norway.<br /><searchLink fieldCode="AU" term="%22Mellgren+G%22">Mellgren G</searchLink>; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Søiland+H%22">Søiland H</searchLink>; Department of Clinical Science, University of Bergen, Norway.; Department of Oncology and Radiotherapy, Stavanger University Hospital, Norway. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2021 Apr; Vol. 15 (4), pp. 957-967. <i>Date of Electronic Publication: </i>2020 Dec 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33252186 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/1878-0261.12865 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 957 Titles: – TitleFull: Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Helland T – PersonEntity: Name: NameFull: Naume B – PersonEntity: Name: NameFull: Hustad S – PersonEntity: Name: NameFull: Bifulco E – PersonEntity: Name: NameFull: Kvaløy JT – PersonEntity: Name: NameFull: Saetersdal AB – PersonEntity: Name: NameFull: Synnestvedt M – PersonEntity: Name: NameFull: Lende TH – PersonEntity: Name: NameFull: Gilje B – PersonEntity: Name: NameFull: Mjaaland I – PersonEntity: Name: NameFull: Weyde K – PersonEntity: Name: NameFull: Blix ES – PersonEntity: Name: NameFull: Wiedswang G – PersonEntity: Name: NameFull: Borgen E – PersonEntity: Name: NameFull: Hertz DL – PersonEntity: Name: NameFull: Janssen EAM – PersonEntity: Name: NameFull: Mellgren G – PersonEntity: Name: NameFull: Søiland H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2021 Apr Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1878-0261 Numbering: – Type: volume Value: 15 – Type: issue Value: 4 Titles: – TitleFull: Molecular oncology Type: main |
| ResultId | 1 |
